MCF Advisors
PROF icon

MCF Advisors’s Profound Medical PROF Stock Holding History

MCF Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Hold
2,000
– – ﹤0.01% 985
2026
Q1 		$13K Hold
2,000
– – ﹤0.01% 911
2025
Q4 		$15.7K Buy
+2,000
New +$12.9K ﹤0.01% 734

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
Letko, Brosseau & Associates
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Ardsley Advisory Partners
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

MCF Advisors's PROF Position: Q2 2026 in Review

MCF Advisors held its Profound Medical (PROF) position steady in Q2 2026 at 2,000 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #985.

MCF Advisors first reported a position in PROF in Q4 2025 and has held it in 3 quarters since. The position peaked at $15.7K in Q4 2025. 55 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • MCF Advisors held 2,000 shares of Profound Medical worth $13.3K as of Q2 2026.
  • MCF Advisors left its Profound Medical share count unchanged in Q2 2026.
  • Profound Medical made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #985 holding.
  • MCF Advisors first reported a position in Profound Medical in Q4 2025 and has held it in 3 quarters since.
  • MCF Advisors's Profound Medical position peaked at $15.7K in Q4 2025.
  • 55 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.